Biomarker Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509247021

Publication Date:

September 23, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Most healthcare experts use analysis assessments to make clear and aid their scientific choice making. Steadily over latest years, the analytic manner has turned out to be more potent by means of the need to preselect sufferers in mild of medicines and licenses. This flow has come to through various factors, which include propelling generation (empowering specialists to degree more particular markers of adequacy), an elevated comprehension of the disease manner, and a more outstanding electricity approximately the individuality of an individual鈥檚 tumor at the molecular degree.
The global market for Biomarker Test was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Biomarker Test was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biomarker Test was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Biomarker Test was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Biomarker Test include F. Hoffmann-La Roche, Novartis, PFIZER, GlaxoSmithKline, GE Healthcare, Medtronics and Quest Diagnostics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biomarker Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biomarker Test by region & country, by Type, and by Application.
The Biomarker Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Test.
Market Segmentation
By Company
F. Hoffmann-La Roche
Novartis
PFIZER
GlaxoSmithKline
GE Healthcare
Medtronics
Quest Diagnostics
Segment by Type:
Cancer
Cardiovascular
Infectious Diseases
Central Nervous System
Segment by Application
Pharma & Biotech Companies
Diagnostic Tool Companies
Healthcare IT/Big Data Companies
Clinical Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biomarker Test manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biomarker Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biomarker Test in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Biomarker Test Product Introduction
1.2 Global Biomarker Test Market Size Forecast
1.3 Biomarker Test Market Trends & Drivers
1.3.1 Biomarker Test Industry Trends
1.3.2 Biomarker Test Market Drivers & Opportunity
1.3.3 Biomarker Test Market Challenges
1.3.4 Biomarker Test Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biomarker Test Players Revenue Ranking (2023)
2.2 Global Biomarker Test Revenue by Company (2019-2024)
2.3 Key Companies Biomarker Test Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biomarker Test Product Offered
2.5 Key Companies Time to Begin Mass Production of Biomarker Test
2.6 Biomarker Test Market Competitive Analysis
2.6.1 Biomarker Test Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biomarker Test Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Test as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cancer
3.1.2 Cardiovascular
3.1.3 Infectious Diseases
3.1.4 Central Nervous System
3.2 Global Biomarker Test Sales Value by Type
3.2.1 Global Biomarker Test Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biomarker Test Sales Value, by Type (2019-2030)
3.2.3 Global Biomarker Test Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharma & Biotech Companies
4.1.2 Diagnostic Tool Companies
4.1.3 Healthcare IT/Big Data Companies
4.1.4 Clinical Laboratories
4.2 Global Biomarker Test Sales Value by Application
4.2.1 Global Biomarker Test Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biomarker Test Sales Value, by Application (2019-2030)
4.2.3 Global Biomarker Test Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biomarker Test Sales Value by Region
5.1.1 Global Biomarker Test Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biomarker Test Sales Value by Region (2019-2024)
5.1.3 Global Biomarker Test Sales Value by Region (2025-2030)
5.1.4 Global Biomarker Test Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biomarker Test Sales Value, 2019-2030
5.2.2 North America Biomarker Test Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biomarker Test Sales Value, 2019-2030
5.3.2 Europe Biomarker Test Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biomarker Test Sales Value, 2019-2030
5.4.2 Asia Pacific Biomarker Test Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biomarker Test Sales Value, 2019-2030
5.5.2 South America Biomarker Test Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biomarker Test Sales Value, 2019-2030
5.6.2 Middle East & Africa Biomarker Test Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biomarker Test Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biomarker Test Sales Value
6.3 United States
6.3.1 United States Biomarker Test Sales Value, 2019-2030
6.3.2 United States Biomarker Test Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biomarker Test Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biomarker Test Sales Value, 2019-2030
6.4.2 Europe Biomarker Test Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biomarker Test Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biomarker Test Sales Value, 2019-2030
6.5.2 China Biomarker Test Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biomarker Test Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biomarker Test Sales Value, 2019-2030
6.6.2 Japan Biomarker Test Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biomarker Test Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biomarker Test Sales Value, 2019-2030
6.7.2 South Korea Biomarker Test Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biomarker Test Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biomarker Test Sales Value, 2019-2030
6.8.2 Southeast Asia Biomarker Test Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biomarker Test Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biomarker Test Sales Value, 2019-2030
6.9.2 India Biomarker Test Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biomarker Test Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Profile
7.1.2 F. Hoffmann-La Roche Main Business
7.1.3 F. Hoffmann-La Roche Biomarker Test Products, Services and Solutions
7.1.4 F. Hoffmann-La Roche Biomarker Test Revenue (US$ Million) & (2019-2024)
7.1.5 F. Hoffmann-La Roche Recent Developments
7.2 Novartis
7.2.1 Novartis Profile
7.2.2 Novartis Main Business
7.2.3 Novartis Biomarker Test Products, Services and Solutions
7.2.4 Novartis Biomarker Test Revenue (US$ Million) & (2019-2024)
7.2.5 Novartis Recent Developments
7.3 PFIZER
7.3.1 PFIZER Profile
7.3.2 PFIZER Main Business
7.3.3 PFIZER Biomarker Test Products, Services and Solutions
7.3.4 PFIZER Biomarker Test Revenue (US$ Million) & (2019-2024)
7.3.5 GlaxoSmithKline Recent Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Profile
7.4.2 GlaxoSmithKline Main Business
7.4.3 GlaxoSmithKline Biomarker Test Products, Services and Solutions
7.4.4 GlaxoSmithKline Biomarker Test Revenue (US$ Million) & (2019-2024)
7.4.5 GlaxoSmithKline Recent Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Profile
7.5.2 GE Healthcare Main Business
7.5.3 GE Healthcare Biomarker Test Products, Services and Solutions
7.5.4 GE Healthcare Biomarker Test Revenue (US$ Million) & (2019-2024)
7.5.5 GE Healthcare Recent Developments
7.6 Medtronics
7.6.1 Medtronics Profile
7.6.2 Medtronics Main Business
7.6.3 Medtronics Biomarker Test Products, Services and Solutions
7.6.4 Medtronics Biomarker Test Revenue (US$ Million) & (2019-2024)
7.6.5 Medtronics Recent Developments
7.7 Quest Diagnostics
7.7.1 Quest Diagnostics Profile
7.7.2 Quest Diagnostics Main Business
7.7.3 Quest Diagnostics Biomarker Test Products, Services and Solutions
7.7.4 Quest Diagnostics Biomarker Test Revenue (US$ Million) & (2019-2024)
7.7.5 Quest Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Biomarker Test Industrial Chain
8.2 Biomarker Test Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biomarker Test Sales Model
8.5.2 Sales Channel
8.5.3 Biomarker Test Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

F. Hoffmann-La Roche
Novartis
PFIZER
GlaxoSmithKline
GE Healthcare
Medtronics
Quest Diagnostics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂